Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States
Rahul Aggarwal, Muthiah Vaduganathan, Nicholas Chiu, Deepak L. Bhatt
Topics & Concepts
MedicineMEDLINEIntensive care medicineEnvironmental healthHeart failureDiseasePublic economicsRisk analysis (engineering)PopulationClinical trialNatural resource economicsDiabetes Treatment and ManagementPotassium and Related DisordersHeart Failure Treatment and Management